More than four-in-five people with Parkinson’s disease have trouble sleeping, a significantly higher rate than the general population, new Irish-led research has found.

Inhibikase Therapeutics announced disappointing results from a Phase 2 trial for its Parkinson’s disease drug, risvodetinib, ...

A new study by researchers at Ireland's Maynooth University, based on patient data gathered by the US-based Michael J. Fox ...

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...

New research uncovers how declining protein clearance mechanisms with age lead to Alzheimer’s, Parkinson’s, and other ...

Sleep problems are very common in people with Parkinson’s disease and are associated with poorer quality of life in patients, ...

Cocker Spaniels Mango, Callie and Dotty, Labradors Hetty, Rosie and Jodie, and Flat-coated Retriever Willow are showing real ...

Stop the Spread. Injecting saline into mouse kidneys did not affect the left or right substantia nigra (top). Injecting fibrils of α-synuclein ablated about half of the dopaminergic neurons (middle ...

DelveInsight's Parkinson's disease Psychosis market Report provides comprehensive insights into the epidemiology and market dynamics across the 7MM. LAS VEGAS , NV, UNITED STATES, January 30, 2025 ...

(HealthDay News) — Hearing impairment is a risk factor for incident Parkinson’s disease (PD), according to a study published online in the February issue of Parkinsonism and Related Disorders.